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Multidrug-resistant Gram-negative bacteria (MDR GNB) 
were found to colonise 60.8% (95% confidence inter-
val: 52.3–68.9) of 143 refugee patients mainly from 
Syria (47), Afghanistan (29), and Somalia (14) admitted 
to the University Hospital Frankfurt, Germany, between 
June and December 2015. This percentage exceeds the 
prevalence of MDR GNB in resident patients four–fold. 
Healthcare personnel should be aware of this and the 
need to implement or adapt adequate infection control 
measures.
Current data provided by Federal Agency of Migration 
and Refugees, Germany, indicate a dramatic increase 
in migration, with most people arriving from Syria, 
Albania, Afghanistan and Iraq [1]. These countries 
are known as countries with high prevalence for mul-
tidrug-resistant Gram-negative bacteria (MDR GNB) 
(Enterobacteriaceae, Acinetobacter baumannii) and 
for meticillin-resistant Staphylococcus aureus (MRSA) 
[2-5]. People from these countries are thus at higher 
risk of being colonised with such pathogens and 
adequate infection prevention measures need to be 
taken to prevent spread in healthcare settings in the 
countries where they seek refuge. Systematic studies 
regarding prevalence of multidrug-resistant organisms 
(MDRO) in refugees are not yet available in the scien-
tific literature. In order to fill this gap, we investigated 
the prevalence of MDR GNB and MRSA in patients 
admitted from refugee (REF) accommodations to the 
University Hospital Frankfurt am Main (UHF), Germany 
between June and December 2015 and compared it 
with prevalence in resident patients.
Investigation of prevalence of multidrug-
resistant organisms in refugee and resident 
patients 
At UHF, all patients admitted from hospitals in coun-
tries with high prevalence or from refugee accommo-
dations are pre-emptively isolated and screened for 
MDRO on the day of admission. The same algorithm is 
applied to resident patients with previous treatment in 
hospitals in countries with high prevalence for MDRO 
and all patients admitted to intensive/intermediate 
care units (ICUs/IMCs). 
During the study period, REF patients were identi-
fied on admission and screened for MDRO by rectal 
swabs for MDR GNB and nasal swabs for MRSA. MDR 
GNB screening was undertaken for extended spectrum 
beta–lactamase (ESBL)-producing Enterobacteriaceae, 
and Enterobacteriaceae and Acinetobacter baumannii 
resistant to piperacillin, any third generation cephalo-
sporin, and fluoroquinolones +/– carbapenems. 
Patients admitted to ICU/IMC within the same period 
were included as comparison group since these 
patients are routinely screened for MDRO. This group 
reflects the demographic and epidemiological charac-
teristics of the resident population not admitted from a 
refugee accommodation (NREF). 
Patients admitted from hospitals in countries with high 
prevalence for MDRO were excluded from the study.
MDRO screening was done in accordance to German 
infection protection law and the infection control 
strategy at UHF. Ethical approval was given by Ethics 
Committee of the UHF.
Laboratory identification of multidrug-
resistant bacteria
For detection of MDR GNB, rectal swabs were col-
lected using Amies collection and transport medium 
(Hain Lifescience, Germany) and streaked onto 
CHROMagar™ ESBL plates (Mast Diagnostica, Paris, 
France). Identification of MDR GNB species was done 
by matrix-assisted laser desorption/ionisation time-of-
flight (MALDI–TOF) mass spectrometry. Antimicrobial 
susceptibility testing was performed using VITEK2 
(bioMérieux, Nürtingen, Germany) according to Clinical 
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and Laboratory Standards Institute (CLSI) guidelines 
[Version M100-S25, 2015] and antibiotic gradient tests 
(bioMérieux).
Carbapenemase-encoding genes were detected via 
PCR analysis and subsequent sequencing from carbap-
enem–resistant Enterobacteriaceae including the bla 
genes for carbapenemases NDM, VIM, IMP, OXA–48, 
and KPC and OXA–23, OXA–24, OXA–51, and OXA–
58 for A. baumannii [6,7]. Carbapenem–resistant A. 
baumannii isolates were assigned to international 
clusters by repetitive element sequence based–PCR 
(DiversiLab®, bioMérieux) [7,8]. 
For the detection of MRSA, moistened nasal swabs 
were inoculated on Brilliance MRSA Agar (Oxoid, Wesel, 
Germany) and identification and antimicrobial suscep-
tibility testing were performed as described above. 
Clonal identity was determined by staphylococcal pro-
tein A (spa) typing using the Ridom StaphType software 
(Ridom GmbH, Würzburg, Germany) [9].
We used the biostatistical data file from University 
Münster, Germany for statistical analyses [10]. 
Confidence intervals (CI) were calculated based on 
binomial distribution and p values (2–tailed) of p≤0.05 
were considered statistically significant.
Prevalence in refugee compared with 
resident patients 
Multidrug-resistant Gram-negative bacteria
Between June and December 2015, a total of 143 REF 
and 1,489 NREF were screened for MDR GNB on day of 
admission. The average age in the two groups was 21.7 
years (range 1-65, SD 16.4) for REF and 64 years (11-94; 
SD 16.2) for NREF, respectively. Of REF patients 84.6% 
were male and of NREF 69.4%. REFs’ countries of origin 
were not available for evaluation in 32 cases (22.4%) 
due to lacking records in patients’ files (Figure).
Of the 143 REF samples 60.8% (for 95% CI and patient 
numbers see Table) were positive for any MDR GNB, sig-
nificantly exceeding the rate in NREF (16.7%) (p≤0.05). 
Among all MDR GNB species, ESBL-producing 
Escherichia coli were detected with higher prevalence 
in REF than in NREF (23.8 vs 4.9%). Prevalence of 
ESBL-producing Klebsiella pneumoniae exceeded the 
prevalence in NREF (4.2 vs 0.8%). Prevalence of ESBL-
producing E. coli with additional resistance to fluoro-
quinolones was higher in REF than that in NREF (26.6 
vs 6.9%) and ESBL-producing K. pneumoniae with addi-
tional resistance to fluoroquinolones were found in a 
higher proportion in REF compared with NREF (4.2 vs 
1.9%). All results were statistically significant.
One REF carried three MDR GNB organisms: ESBL-
producing E. coli with additional resistance to fluo-
roquinolones, ESBL-producing K. pneumoniae and 
carbapenem–resistant A. baumannii. Two REF were 
positive for two MDR GNB organisms each; one carried 
E. coli with additional resistance to fluoroquinolones 
and ESBL-producing K. pneumoniae with additional 
resistance to fluoroquinolones, one carried ESBL-
resistant E. coli and ESBL-resistant E. coli with addi-
tional resistance to fluoroquinolones. 
In REF, three carbapenem–resistant isolates were 
detected: one carbapenem–resistant K. pneumoniae, 
expressing VIM–1 which is frequently detected in south-
ern Europe [11], and two carbapenem–resistant A. bau-
mannii (1.4%), harbouring carbapenemases OXA–23 
and OXA–24, respectively. Strain typing revealed that 
these isolates belong to international cluster II which is 
disseminated worldwide and is frequently associated 
with OXA carbapenemases [7,8]. 
In NREF, 16 (1.1%) carbapenem–resistant isolates were 
detected. Two of these were identified as K. pneumo-
niae expressing OXA–48, one expressed OXA–48 and 
NDM–1, and in seven isolates no specific carbapen-
emase gene was detected. Carbapenem–resistant 
E. coli isolates were detected in three cases with all 
of them expressing OXA–48. Carbapenem–resist-
ant Enterobacter cloacae strains were detected in two 
cases with one expressing OXA–48 and one without 
specific carbapenemase gene detection. Carbapenem–
resistant A. baumannii was detected in one case; no 
other carbapenemase than species–specific OXA–51 
was detectable.
Meticillin-resistant Staphylococcus aureus
Screening for MRSA was performed for 143 REF and 
1,170 NREF. In REF, eight MRSA isolates (5.6%; 95%CI: 
2.5–10.7) were detected, which significantly exceeded 
the prevalence in NREF where 14 isolates were posi-
tive (1.2%; 95%CI: 0.6–2.0). Spa types in REF (n=1 not 
Figure
Countries of origin of refugees screened for 
multidrug-resistant Gram-negative bacteria 
and meticillin resistant Staphylococcus aureus, 
Frankfurt, Germany June‒October 2015 (n=143)
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determined) were t223 (n=2), t386, t790, t852, t1532, 
and t10343 (n=1 each) and spa types in NREF were 
t003 (n=8), t032 (n=2), t008, t012, t034, and t127 (n=1 
each).
Discussion and conclusion
Having protocols in place to control infectious disease 
transmission in hospitals is good practice to ensure 
patient safety and should be the focus of preventive 
efforts. While travel to countries with high prevalence, 
medical tourism, or contact to local healthcare in such 
countries have been identified as contributing to the 
transmission and geographical spread of MDRO world-
wide [2,3,5,12], considerations on limiting the spread 
of MDRO should be expanded to people coming from 
or passing through countries with high prevalence and 
seeking refuge, for example in Germany. In terms of 
hospital infection control strategies, this population 
may represent a yet unidentified risk in countries with 
low endemicity. 
Our study has revealed a strong link between the sta-
tus REF and carriage of MDR GNB and MRSA exceed-
ing that of NREF, which might constitute an inherent 
risk of introduction in another countries healthcare 
system, such as previously observed in Turkey, where 
NDM-1-producing A. baumannii strains were most likely 
imported from neighbouring Syria [13]. MRSA spa types 
detected in REF were less common in Germany whereas 
NREF colonised with MRSA were found to harbour spa 
types known to be most frequent in Germany [14].
According to the guidelines by the infection pre-
vention commission (KRINKO) at the Robert–Koch 
Institute, Berlin, Germany, isolation is recommended 
for all hospitalised patients for the following patient 
groups: patients with MRSA [15] and patients with 
Table
Distribution of multidrug-resistant Gram-negative bacteria in refugee compared with resident patients, Frankfurt, Germany 
July‒December 2015
Patients admitted from refugee accommodations 
(REF) 
Resident patients not admitted from refugee 
accommodation (NREF)
Total number of patients 143 1,489
% (n) 95% CI % (n) 95% CI
Positive for MDR GNBa 60.8 (87) 52.3–68.9 16.7 (250) 14.9–18.8
Escherichia coli ESBLb 23.8 (34) 17.1–31.5 4.9 (73) 3.8–6.1
Escherichia coli ESBL/FQb 26.6 (38) 19.5–34.6 6.9 (104) 5.7–8.4
Escherichia coli Carba
0.0 (0) 0.0–2.5 0.2 (3) 0.04–0.5
Carbapenemases  
None
Carbapenemases  
OXA–48 (3)
Klebsiella pneumoniae ESBLb 4.2 (6) 1.5–8.9 0.8 (12) 0.4–1.4
Klebsiella pneumoniae ESBL/FQb 4.2 (6) 1.5–8.9 1.9 (28) 1.2–2.7
Klebsiella pneumoniae Carba
0.7 (1) 0.02–3.8 0.6 (10) 0.3–1.2
Carbapenemases  
VIM–1(1)
Carbapenemases  
OXA–48 (2) 
OXA–48 and NDM–1 (1) 
No carbapenemase detected (7)
Enterobacter cloacae Ceph/FQ 0.0 (0) N.a. 0.5 (8) 0.2–1.1
Enterobacter cloacae Carba
0.0 (0) N.a. 0.1 (2) 0.02–0.5
Carbapenemases  
None
Carbapenemases  
OXA–48 (1) 
No carbapenemase detected (1)
Enterobacter aerogenes Ceph/FQ 0.0 (0) N.a 0.2 (3) 0.04–0.5
Citrobacter freundii Ceph/FQ 0.0 (0) N.a. 0.3 (4) 0.07–0.7
Klebsiella oxytoca Ceph/FQ 0.0 (0) N.a. 0.06 (1) 0.002–0.3
Acinetobacter baumannii 
Ceph/FQ 0.0 (0) N.a 0.06 (1) 0.002–0.3
Acinetobacter baumannii Carba
1.4 (2) 0.2–0.5 0.06 (1) 0.002–0.3
Carbapenemasesc  
OXA–23 (1) 
OXA–24 (1)
Carbapenemasesc  
No carbapenemase detected (1)
Carba: resistance to carbapenems; ESBL: extended beta-spectrum lactamase-producing; FQ: resistance to fluoroquinolones; MDR GNB: 
multidrug-resistant Gram-negative bacteria. 
a Organism and resistance pattern.
b Values in neighboring columns vary statistically significantly (p≤0.05).
c Other than species-specific OXA–51.
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carbapenem–resistant MDR GNB [16]. Additionally, in 
hospital units at high risk for nosocomial transmissions 
such as ICUs and IMCs, isolation of patients with MDR 
GNB resistant to cephalosporins and fluoroquinolones 
and/or MDR GNB with resistance to carbapenems is 
recommended. In our study the latter would apply to 
32.9% of REF versus 10.9% of NREF patients. Taking all 
KRINKO guidelines (including MRSA) into account, a 
total of 38.5% of REF and 12.1% of NREF would qualify 
for isolation. The demonstrated high MDRO prevalence 
in our REF study population calls for intensive efforts in 
hospital hygiene to guarantee best medical practice for 
every single patient.
While it is hardly possible to predict any evolutionary or 
geographical success of these MDRO strains in German 
hospitals or elsewhere in Europe, our small-scale inves-
tigation provides some evidence for the importance of 
screening and aligned hygiene measures in patients 
admitted from refugee accommodations. It is hard to 
estimate the whether the REF population in the UHF 
setting is representative of the overall refugee popu-
lation in Germany. However, a study also conducted 
in Frankfurt am Main but in unaccompanied refugee 
minors (<18 years- old) in refugee centres also found a 
high prevalence of ESBL-producing Enterobacteriaceae 
(35%) even though lower than that in our study [17]. 
One limitation of our study may be the pre–selection 
of NREF. As mentioned above, this group consists of 
patients admitted to ICUs and IMCs: considering that 
they are critically ill, possible prior antibiotic treatment 
might have resulted in increased prevalence of MDRO 
in the NREF group used for comparison. This might 
lead to an overestimation of the MDRO prevalence in 
our NREF group and thus to an underestimation of the 
difference in MDRO prevalences between REF and NREF 
patients. 
Unfortunately, information regarding refugees’ itin-
eraries were not available due to missing records in 
the patient files and the language barrier on hospital 
admission. Such information, however, would help to 
better understand the origin and transmission routes 
of MDROs. For example refugees might have acquired a 
particular MDRO during their transit through a country 
with high prevalence. Future investigations on clonal 
relatedness and comparisons with major endemic 
clones should allow to analyse the spread of MDRO in 
connection with the movements of refugees.
At UHF, all REF are screened for MDRO and pre–emp-
tively isolated on the day of admission. In case of nega-
tive screening results, REF are released from isolation. 
In case of positive MDR GNB and/or MRSA results, REF 
remain in isolation during their entire stay. Since June 
2015, this procedure has been implemented and guar-
antee best medical practice for every individual patient 
at UHF, independently of their country of origin.
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